Perceptions regarding strategic and structural entry barriers
نویسندگان
چکیده
منابع مشابه
Perceptions of Mexican women regarding barriers in mental Heath Services in primary care
BACKGROUND The recent mental health care reforms in Mexico call for the regular evaluation of the services provided. This involves analyzing the opinions of those who utilize them on a daily basis, particularly women, since they are the main health service users. This study explores the barriers to mental health care perceived by a group of women attending primary care centers. METHOD A quali...
متن کاملNotes on Strategic Entry Deterrence
As a manager, you prefer that other firms not enter your markets. Sometimes you’re lucky and you’re protected by natural barriers to entry. Examples of these are legal protections on intellectual property (e.g., a patented product), government regulations limiting entry (e.g., restrictive zoning), and the amount of industry-specific capital investments needed to compete effectively. Many times,...
متن کاملBarriers to Technology Adoption and Entry∗
A key feature of recent work on barriers to technology adoption is the assumption that monopoly rights of insiders are limited by the ability of industry outsiders to enter. This paper endogenizes the decision of a government to provide barriers to technology adoption alone or in combination with barriers to entry of outsiders. Using a political economy model, we find that a government provides...
متن کاملEntry barriers and medical board funding autonomy
In this paper we develop and test the hypothesis that institutional funding arrangments affect the extent to which public agencies are influenced by special interests. We test this hypothesis using data on state medical boards. In 1989, medical boards in twenty-one states received budget appropriations from their legislatures. The remaining boards operated independent of legislative control, fi...
متن کاملBiologic Drugs, Biosimilars, and Barriers to Entry.
Biologic drugs represent an important new category of drugs in the effort to improve health outcomes in this country. Yet, these cutting-edge drugs are often cost prohibitive, preventing access for many Americans. Recognizing the need for more affordable, generic substitutes for biologic drugs—or biosimilars—Congress recently created a biosimilars approval pathway that would enable these cheape...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Small Business Economics
سال: 2009
ISSN: 0921-898X,1573-0913
DOI: 10.1007/s11187-008-9159-1